Marzenna Wiranowska

656 total citations
35 papers, 485 citations indexed

About

Marzenna Wiranowska is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Marzenna Wiranowska has authored 35 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Biomaterials. Recurrent topics in Marzenna Wiranowska's work include Nanoparticle-Based Drug Delivery (6 papers), Glioma Diagnosis and Treatment (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Marzenna Wiranowska is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Glioma Diagnosis and Treatment (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Marzenna Wiranowska collaborates with scholars based in United States and Poland. Marzenna Wiranowska's co-authors include Paul E. Gottschall, Joseph Johnson, S Szmigielskí, Norma Alcantar, Xiaoling Chen, Leon D. Prockop, Rana Falahat, Christopher P. Phelps, Li T. Chen and L. Colina and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Marzenna Wiranowska

34 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marzenna Wiranowska United States 15 194 74 66 62 56 35 485
Nina Bauer Germany 9 277 1.4× 85 1.1× 63 1.0× 67 1.1× 90 1.6× 15 546
Hye Young Shin South Korea 14 372 1.9× 46 0.6× 62 0.9× 47 0.8× 37 0.7× 29 723
Dunja Lukovic Spain 18 543 2.8× 61 0.8× 60 0.9× 27 0.4× 49 0.9× 31 868
Hyo Sang Jang United States 18 434 2.2× 90 1.2× 101 1.5× 77 1.2× 19 0.3× 29 852
S. Biswas United States 15 301 1.6× 53 0.7× 24 0.4× 76 1.2× 56 1.0× 30 617
Ran An China 13 324 1.7× 47 0.6× 31 0.5× 72 1.2× 48 0.9× 31 613
Sonja Kallendrusch Germany 16 241 1.2× 24 0.3× 131 2.0× 60 1.0× 69 1.2× 29 609
Pítia Flores Ledur Brazil 10 217 1.1× 34 0.5× 99 1.5× 32 0.5× 65 1.2× 11 441
Minxuan Sun China 16 406 2.1× 72 1.0× 82 1.2× 25 0.4× 89 1.6× 39 781

Countries citing papers authored by Marzenna Wiranowska

Since Specialization
Citations

This map shows the geographic impact of Marzenna Wiranowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marzenna Wiranowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marzenna Wiranowska more than expected).

Fields of papers citing papers by Marzenna Wiranowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marzenna Wiranowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marzenna Wiranowska. The network helps show where Marzenna Wiranowska may publish in the future.

Co-authorship network of co-authors of Marzenna Wiranowska

This figure shows the co-authorship network connecting the top 25 collaborators of Marzenna Wiranowska. A scholar is included among the top collaborators of Marzenna Wiranowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marzenna Wiranowska. Marzenna Wiranowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiranowska, Marzenna. (2024). Advances in the use of chitosan and chlorotoxin- functionalized chitosan polymers in drug delivery and detection of glioma – A review. Carbohydrate Polymer Technologies and Applications. 7. 100427–100427. 14 indexed citations
3.
Wiranowska, Marzenna, Ryan Toomey, Rana Falahat, & Norma Alcantar. (2019). Abstract 3615: Design for a flexible localized drug delivery system. Cancer Research. 79(13_Supplement). 3615–3615.
4.
Falahat, Rana, Marzenna Wiranowska, Ryan Toomey, & Norma Alcantar. (2016). ATR-FTIR analysis of spectral and biochemical changes in glioma cells induced by chlorotoxin. Vibrational Spectroscopy. 87. 164–172. 9 indexed citations
5.
Falahat, Rana, et al.. (2014). Abstract 5410: Enhanced targeting delivery to tumor cells using mucoadhesive chitosan and chlorotoxin. Cancer Research. 74(19_Supplement). 5410–5410. 3 indexed citations
6.
Wiranowska, Marzenna, et al.. (2012). Abstract 2897: Preferential drug delivery to cancer cells than to normal cells by using the Niosome-Chitosan Thermo-responsive Double Package System (NCTR-DPS). Cancer Research. 72(8_Supplement). 2897–2897. 2 indexed citations
7.
Wiranowska, Marzenna, L. Colina, & Joseph Johnson. (2011). Clathrin-mediated entry and cellular localization of chlorotoxin in human glioma. Cancer Cell International. 11(1). 27–27. 34 indexed citations
8.
Senzer, Neil, Jeffrey J. Raizer, Sui Shen, et al.. (2009). A phase I evaluation of intravenous (IV) 131I-chlorotoxin delivery to solid peripheral and intracranial tumors. Journal of Clinical Oncology. 27(15_suppl). e14507–e14507. 10 indexed citations
9.
Wiranowska, Marzenna, et al.. (2009). Modulation of hyaluronan production by CD44 positive glioma cells. International Journal of Cancer. 127(3). 532–542. 34 indexed citations
10.
Wiranowska, Marzenna, et al.. (2007). CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma. PubMed. 35(2-3). 159–172. 37 indexed citations
11.
Chen, Xiaoling, Paul E. Gottschall, Li T. Chen, Marzenna Wiranowska, & Christopher P. Phelps. (2002). Role and Mechanisms of Interleukin-1 in the Modulation of Neurotoxicity. NeuroImmunoModulation. 10(4). 199–207. 65 indexed citations
12.
Menzies, Robert D., et al.. (1996). The Effect of Interferon-α on the Pituitary-Adrenal Axis. Journal of Interferon & Cytokine Research. 16(8). 619–629. 19 indexed citations
13.
Wiranowska, Marzenna, et al.. (1994). Interferon entry through the blood-brain barrier in glioma and its effect on lipoxygenase activity.. PubMed. 14(3A). 1121–6. 6 indexed citations
14.
Wiranowska, Marzenna, et al.. (1993). Inhibition of cell proliferation and glutathione S-transferase by ascorbyl esters and interferon in mouse glioma. Journal of Neuro-Oncology. 16(1). 1–10. 18 indexed citations
15.
Wiranowska, Marzenna, et al.. (1992). Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model. Journal of Neuro-Oncology. 14(3). 225–36. 21 indexed citations
16.
Wiranowska, Marzenna, Thomas C. Wilson, Kary E. Thompson, & Leon D. Prockop. (1989). Cerebral Interferon Entry in Mice after Osmotic Alteration of Blood–Brain Barrier. Journal of Interferon Research. 9(3). 353–362. 19 indexed citations
17.
Wiranowska, Marzenna, et al.. (1988). A mouse model for the study of blood-brain barrier permeability. Journal of Neuroscience Methods. 26(2). 105–109. 9 indexed citations
18.
Szmigielskí, S, et al.. (1975). Karyometric observations of WISH cell cultures irradiated with 3 GHz microwaves.. PubMed. 13(3-4). 151–9. 1 indexed citations
19.
Szmigielskí, S, et al.. (1975). EFFECT OF MICROWAVES ON CELL FUNCTION AND VIRUS REPLICATION IN CELL CULTURES IRRADIATED IN VITRO. Annals of the New York Academy of Sciences. 247(1). 263–274. 18 indexed citations
20.
Szmigielskí, S, J. Jeljaszewicz, & Marzenna Wiranowska. (1975). ACUTE STAPHYLOCOCCAL INFECTIONS IN RABBITS IRRADIATED WITH 3‐GHz MICROWAVES*. Annals of the New York Academy of Sciences. 247(1). 305–311. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026